Promising Skin-Cancer Vaccine Fails Key Trial - Presented by: The Aol. On Network

The failure of a GlaxoSmithKline cancer vaccine in a clinical trial is a setback for a hot area of medicine that seeks to harness the body’s immune system to fight tumors. Jeanne Whalen has details on the News Hub.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
HTZ $ 30.33 1.23 ▼ 3.90%
BAC $ 15.52 0.07 ▲ 0.45%
AAPL $ 100.57 0.04 ▲ 0.04%
NOK $ 8.13 0.11 ▲ 1.37%
FOLD $ 5.50 0.93 ▲ 20.35%
JCP $ 10.33 0.08 ▲ 0.78%
IRF $ 39.10 12.54 ▲ 47.21%
GE $ 26.36 0.31 ▲ 1.19%

As of 8/20/2014, 04:04 PM
More Most Active